The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
07/08/2009
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Description of Modification
Correction of URL Link
Document Type:
Modification to Previous
Grants Notice
Funding Opportunity Number:
W81XWH-09-MOMRP-PTSDTX
Opportunity Category:
Discretionary
Posted Date:
Jul 08, 2009
Creation Date:
Jul 08, 2009
Original Closing Date for Applications:
Nov 24, 2009
Current Closing Date for Applications:
Nov 24, 2009
Archive Date:
Dec 24, 2009
Funding Instrument Type:
Cooperative Agreement
Grant
Procurement Contract
Category of Funding Activity:
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
2
Estimated Total Program Funding:
$3,500,000
Award Ceiling:
$3,500,000
Award Floor:
$0
CFDA Number(s):
12.420
--
Military Medical Research and Development
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Agency Name
Dept. of the Army -- USAMRAA
Description
U.S. Army Soldiers are enduring unyielding high operational tempo in garrison and the combat field of operations in order to keep pace with ongoing Wartime mission requirements. The high tempo and increasingly common multiple deployments present many human physical and psychological challenges (Military Health Advisory Team IV (MHAT-IV), 2006; MHAT-V, 2008) that have a rippling effect on Soldier well-being as well as Army retention and recruitment. According to seminal work by Hoge et al. (2004), an estimated 17% of active duty Soldiers screened positive for deployment-related Posttraumatic Stress Disorder (PTSD) post deployment to Operation Iraqi Freedom or Operation Enduring Freedom (OIF/OEF); recent estimates (MHAT V, 2008) were suggested to be within the estimated ranges. PTSD is often complicated by other behavioral health problems including depression, alcohol and other drug (AOD) use, and suicide/suicide-related behavior (e.g., Seal, Bertenthal, Miner, Sen, & Marmar, 2007). All evidence-based treatments, including cognitive-behavioral based exposure therapies (Foa, Keane, & Friedman, 2000), Eye Movement Desensitization and Reprocessing (EMDR) therapy (e.g., Rothbaum, 1997; Shapiro, 2001), and selective serotonin reuptake inhibitors (SSRIs) (e.g., Brady et al., 2000), are only partially effective (Friedman, Keane, & Resick, 2007). The complicated presentation of PTSD may likely contribute to the finding that existing evidence-based treatments are up to 50% ineffective in treating PTSD symptoms.
If you have difficulty accessing the full announcement
electronically, please contact:
Ethan J. Mueller
Grants Officer
Phone 301-619-2192
Grants Officer
Synopsis Modification History
The following files represent the modifications to this synopsis
with the changes noted within the documents. The list of files is
arranged from newest to oldest with the newest file representing the
current synopsis. Changed sections from the previous document are shown
in a light grey background.
